Genetic epidemiology and primary care

British Journal of General Practice

Volumn 56, Issue 524, 2006, Pages 214-221

  Smith, Blair H ^a   Watt, Graham C M ^b   Campbell, Harry ^c   Sheikh, Aziz ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Epidemiology; Genetics; Primary care; Public engagement

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; CYTOCHROME P450 2C9; DOPAMINE 2 RECEPTOR; NICOTINE DERIVATIVE; NICOTINE PATCH; WARFARIN;

ARTICLE; BLEEDING; BREAST CANCER; CARDIOVASCULAR DISEASE; COLORECTAL CANCER; CONFIDENTIALITY; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DIABETES MELLITUS; DOCTOR PATIENT RELATION; DRUG COST; DRUG RESPONSE; GENE MAPPING; GENE MUTATION; GENERAL PRACTICE; GENERAL PRACTITIONER; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEMOGLOBINOPATHY; HUMAN; MEDICAL ETHICS; NICOTINE REPLACEMENT THERAPY; OSTEOPOROSIS; PENETRANCE; PHARMACOGENETICS; PHENYLKETONURIA; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PROGNOSIS; TOBACCO DEPENDENCE; UNITED KINGDOM;

EPIDEMIOLOGY; FAMILY PRACTICE; GENETICS; HUMANS;

EID: 33644817250     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Austin MA, Harding S, McElroy C. Genebanks: a comparison of eight proposed international genetic databases. Community Genet 2003; 6: 37-45.
2. Khoury MJ, Millikan R, Little J, Gwinn M. The emergence of epidemiology in the genomics of age. Int J Epidemiol 2004; 33: 936-944.
3. Anderson MW. A 500 000-person study? Gene-environment interactions would be focus of NIH-led effort. http://www.the-scientist.com/news/20040526/04/ (accessed 3 Feb 2006).
4. Shpilberg O, Dorman JS, Ferrell RE, et al. The next stage: molecular epidemiology. J Clin Epidemiol 1997; 50: 633-638.
5. Berger A. UK genetics database plans revealed. BMJ 2001; 322: 1018.
6. Biobank. UK Biobank: Improving the health of future generations. http://www.ukbiobank.ac.uk/ (accessed 25 Jan 2006).
7. Generation Scotland. Addressing the health and wealth of Scotland. http://www.generationscotland.org (accessed 25 Jan 2006).
8. Eesti Geenivaramu. Homepage. http://www.geenivaramu.ee/ (accessed 25 Jan 2006)
9. deCode. deCode genetics. http://www.decode.is/ (accessed 25 Jan 2006).
10. Emery J, Watson E, Rose P, Andermann A. A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract 1999; 16: 426-445.
11. Emery J, Hayflick S. The challenge of integrating genetic medicine into primary care. BMJ 2001; 322: 1027-1030.
12. Knottnerus JA. Community genetics and community medicine. Fam Pract 2003; 20: 601-606.
13. Qureshi N, Modell B, Modell M. Raising the profile of genetics in primary care. Nat Rev Genet 2004; 5: 783-790.
14. Mitchell RJ, Farrington SM, Dunlop MG, Campbell H. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 2002; 156: 885-902.
15. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117-1130.
16. Ralston SH. Genetic determinants of susceptibility to osteoporosis. Curr Opin Pharmacol 2003; 3: 286-290.
17. Bell J. The new genetics in clinical practice. BMJ 1998; 316: 618-620.
18. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48: 232-242.
19. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170.
20. Khoury MJ. Genetic epidemiology. In: Rothman KJ, Greenland S, Modem epidemiology. 2nd edn. Philadelphia: Lippincott-Raven, 1998: 609-622.
21. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. A scientific foundation for using genetic information to improve health and prevent disease. Oxford. Oxford University Press, 1993.
22. Davey Smith G, Ebrahim S. 'Mendelian randomisation': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32: 1-22.
23. Khoury MJ, Little J, Burke W (eds). Human genome epidemiology. New York. Oxford University Press, 2004.
24. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358: 1356-1360.
25. Colhoun H, McKeigue PM. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-872.
26. Collins FS, McKusick VA. Implications of the human genome project for medical science. JAMA 2001; 285: 540-544.
27. Aitman TJ. DNA microarrays in medical practice. BMJ 2001; 323: 611-615.
28. Hapgood R. The potential and limitations of personalised medicine in primary care. Br J Gen Pract 2003; 53: 915-916.
29. Tucker G. Pharmacogenetics - expectations and reality. BMJ 2004; 329: 4-6.
30. Watt GCM. What will the new genetic information do for us? J Health Serv Res Policy 2004; 9: 186-188.
31. Johnstone EC, Yudkin PL, Hey K, et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics 2004; 14: 83-90.
32. Yudkin P, Munafo M, Hey K, et al. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial. BMJ 2004; 328: 989-990.
33. Aithal G, Day C, Keseven P, Daly A. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and the risk of bleeding complications. Lancet 1998; 353: 717-719.
34. Mitchell RJ, Brewster D, Campbell H, et al. Accuracy of reporting of family history of colorectal cancer. Gut 2004; 53: 291-295.
35. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352: 1851-1860.
36. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRACT. Science 1994; 266: 66-71.
37. Wooster R, Bignell G, Lancester J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-792.
38. Armstrong K, Scwartz JS, Randall T, et al. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/ 2 mutations: a decision analysis. J Clin Oncol 2004; 22: 978-980.
39. Easton D, Bishop D, Ford D, Croskford G. Genetic linkage analysis in familial breast and ovarian cancer results from 214 families. Am J Hum Genet 1993; 52: 678-701
40. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003; 361: 567-571.
41. Wright A, Carothers A, Campbell H. Gene environment interaction: the BioBank UK Study. Pharmacogenomics J 2002; 2: 75-82.
42. Sullivan FM, Pell JP, Sweetland M, Morris AD. How could primary care meet the informatics needs of UK Biobank? A Scottish proposal. Inform Prim Care 2003; 11: 129-135.
43. Hayward B, Mortimer I, Brunwin T. Survey of public attitudes towards conduct in public life. London: Committee on Standards in Public Life, 2004. www.public-standards.gov.uk/research/researchreport.pdf (accessed 25 Jan 2006).
44. Watt GCM. General practice and the epidemiology of health and disease in families [Pickles lecture]. Br J Gen Pract 2004; 54: 939-944.
45. Marsden W, Duffy R, Sullivan F. A short report on the recruitment potential of two Scottish primary care trust areas to UK Biobank. Dundee: TayRen/Fresco, 2002.
46. Smith BH, Hannaford PC, Elliott AM, et al. The 'number needed to sample' in primary care research. Comparison of two primary care sampling frames for chronic back pain. Fam Pract 2005; 22: 205-214.
47. Correa-Villasenor, Cragan J, Krucik J, et al. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol 2003; 67: 617-624.
48. Walker M, Shaper AG, Lennon L, Whincup P. Twenty year follow-up of a cohort based in general practices in 24 British towns. J Public Health Med 2000; 22: 479-485.
49. Smith BH. Chronic pain: a challenge for primary care. Br J Gen Pract 2001; 51: 524-526.
50. Wessely C, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999; 354: 936-939.
51. Crombie IK, Davies HTO. Selection bias in pain research. Pain 1998; 74: 1-3.
52. Campbell H. Rudan I. Interpretation of genetic association studies in complex disease. Pharmacogenomics J 2002; 2: 349-360.
53. The Medical Research Council General Practice Research Framework. Homepage. http://www.mrc-gprf.ac.uk/ (accessed 25 Jan 2006).
54. The Scottish School of Primary Care. Scottish Practices and Professionals Involved in Research (SPPIRe). http://www.show.scot.nhs.uk/sspc/sppire/sppire1.asp (accessed 25 Jan 2006).
55. Department of Health. R&D in primary care national working group report. London: Department of Health, 1997.
56. Silagy C, Carson N. Factors affecting the level of interest in activity in primary care research among general practitioners. Fam Pract 1989; 6: 173-176.
57. Ward L, Innes M. Electronic medical summaries in general practice - considering the patient's contribution. Br J Gen Pract 2003; 53: 293-297.
58. Golding J, Pembrey M, Jones R, the ALSPAC Study Team. ALSPAC - the Avon Longitudinal Study of Parents and Children. 1. Study methodology. Paediatr Perinat Epidemiol 2001; 15: 74-87.
59. Pembrey M, ALSPAC Study Team. The Avon Longitudinal Study of Parents and Children (ALSPAC): a resource for genetic epidemiology. Ear J Endocrinol 2004; 151(Suppl 3): U125-129.
60. Callard RE, Hamvas R, Chatterton C, et al. An interaction between the IL-4R gene and infection with atopic eczema in young children. Clin Exp Allergy 2002; 32: 990-994.
61. CARTaGENE. A genetic map of Quebec. http://www.cartagene.qc.ca/ (accessed 25 Jan 2006).
62. Chen Z, Lee L, Chen J, et al. Cohort profile: The Kadoorie Study of Chronic Disease in China (KSCDC). Int J Epidemiol 2005; 34: 1243-1249.
63. Putnina A. Exploring the articulation of agency: population genome project in Latvia. www.ifz.tugraz.at/index_en.php/filemanager/download/ 122/putnina.pdf (accessed 3 Feb 2005).
64. Uman Genomics. Homepage. http://www.umangenomics.com/ (accessed 25 Jan 2006).
65. Genom EU Twin. Studies of European volunteer twins to identify genes underlying common diseases. http://www.genomeutwin.org/ (accessed 25 Jan 2006).
66. Noon JP, Walker BR, Webb DJ, et al. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99: 1873-1879.
67. Harrap SB, Fraser R, Inglis GC, et al. Abnormal epinephrine release in young adults with high personal and high parental blood pressures. Circulation 1997; 96: 556-561.
68. Harrap SB, Cumming AD, Davies DL, et al. Glomerular hyperfiltration, high renin and low-extracellular volume in high blood pressure. Hypertension 2000; 35: 952-957.